- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
Chinese guidelines on the management of ascites and its related complications in cirrhosis
Authors
Authors and affiliations
Chinese Society of Hepatology, Chinese Medical AssociationXiaoyuan XuEmail authorZhongping DuanHuiguo DingWengang LiJidong JiaLai WeiEnqiang LinghuHui Zhuang
Chinese Society of Hepatology, Chinese Medical Association
Xiaoyuan Xu
1Email author
Zhongping Duan
2
Huiguo Ding
3
Wengang Li
4
Jidong Jia
5
Lai Wei
6
Enqiang Linghu
7
Hui Zhuang
8
1.Department of Infectious DiseasesPeking University First HospitalBeijingChina
2.Artificial Liver CenterBeijing You-An Hospital, Capital Medical UniversityBeijingChina
3.Center for Hepatology and Gastroenterology, Beijing You-An HospitalCapital Medical UniversityBeijingChina
4.Liver Tumor Diagnosis, Treatment and Research CenterBeijingChina
5.Liver Research Center, Beijing Friendship HospitalCapital Medical UniversityBeijingChina
6.Institute of HepatologyPeking University People’s HospitalBeijingChina
7.Department of GastroenterologyChinese PLA General HospitalBeijingChina
8.Department of Pathogen BiologyPeking University Health Science CenterBeijingChina
Guidelines
First Online: 18 January 2019
2 Shares 1.1k Downloads
Abstract
The Chinese Society of Hepatology developed the current guidelines for the Management of Ascites and Its Related Complications in Cirrhosis based on the published evidences and the panelists’ consensus. The guidelines provided recommendations for the diagnosis and management of cirrhotic ascites emphasizing a step-wise approach with the first-, second-, and third-line therapy. For refractory ascites, vasoconstrictors and albumin are recommended for splanchnic vasodilation and selective vasopressin (V2) receptor antagonists for moderate-to-severe hyponatremia. For spontaneous bacterial peritonitis, empirical anti-infection treatment was recommended based on the local microbiological examination of community- or hospital-acquired infections. For hepatorenal syndrome, the administration of vasopressor terlipressin and albumin is recommended.
Keywords
Liver cirrhosis Ascites SBP Hepatorenal syndrome Diagnosis Therapy Guidelines |
|